Magic Mushrooms Help Smokers Quit in New Study

Quitting smoking is one of the hardest things a person can do, but scientists just found a surprising ally in the fight against nicotine addiction.

Researchers at Johns Hopkins University discovered that combining talk therapy with one dose of psilocybin, the active compound in magic mushrooms, helped smokers quit with dramatically better results than traditional methods. Six months after treatment, participants who received psilocybin had six times higher odds of staying smoke-free compared to those using nicotine patches.

The numbers behind smoking make this discovery especially meaningful. Around 70% of adult smokers want to quit, but less than one in ten succeed in any given year. Nicotine is as addictive as cocaine and heroin, making tobacco one of the toughest drugs to quit.

What makes psilocybin work isn't fully understood, but the answer seems philosophical rather than purely chemical. Nearly all participants who successfully quit reported the same insight: their life priorities suddenly shifted, and smoking no longer fit into their values. "The magnitude of the experience kind of overshadowed this previously insurmountable psychological challenge of quitting smoking," says Matthew Johnson, the study's lead author.

The research involved 42 people who had smoked for an average of 31 years and tried quitting multiple times before. Each received psilocybin alongside structured cognitive behavioral therapy over 15 weeks. One participant reported zero withdrawal symptoms. Another described feeling "reprogrammed" so that touching a cigarette wasn't even possible anymore.

The Ripple Effect

This research represents more than just a new tool for individual smokers. Smoking remains the leading preventable cause of death and disease worldwide. The United States hasn't approved a new smoking cessation medication in 20 years, leaving millions with limited options.

If these results hold up in larger trials, psilocybin therapy could become a game-changer for public health. The Psychedelic Medicine Association calls this work "one of the most compelling and potentially impactful lines of inquiry in psychedelic science" when it comes to saving lives.

Johnson and his team are now working to understand exactly how psilocybin creates these lasting changes. While psychedelic drugs remain tightly controlled in most countries, growing evidence suggests they could help treat various mental health conditions and addictions beyond smoking.

For the millions who've tried and failed to quit smoking, this research offers something that's been missing: genuine hope backed by solid science.